← FDA Drug Approvals (Drugs@FDA)

SANDRIL

NDA · New Drug Application · Sponsor: LILLY · Approved 1981-10-22

Drug application

FDA Application #

NDA010012

Application type

New Drug Application

Brand name

SANDRIL

Generic name

Reserpine

Active ingredients

RESERPINE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

LILLY

First approval

1981-10-22

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown